Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
Tagalakis AD, Maeshima R, Yu-Wai-Man C, Meng J, Syed F, Wu LP, Aldossary AM, McCarthy D, Moghimi SM, Hart SL. Tagalakis AD, et al. Among authors: maeshima r. Acta Biomater. 2017 Mar 15;51:351-362. doi: 10.1016/j.actbio.2017.01.048. Epub 2017 Jan 18. Acta Biomater. 2017. PMID: 28110069
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.
Bilip M, Shah S, Mathiyalakan M, Tagalakis AD, Hart SL, Maeshima R, Eaton S, Orford M, Irving E, Di Florio A, Simons C, Stoker AW. Bilip M, et al. Among authors: maeshima r. J Drug Target. 2020 Jul;28(6):643-654. doi: 10.1080/1061186X.2019.1710157. Epub 2020 Jan 14. J Drug Target. 2020. PMID: 31903789 Free PMC article.
Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival.
Tagalakis AD, Jayarajan V, Maeshima R, Ho KH, Syed F, Wu LP, Aldossary AM, Munye MM, Mistry T, Ogunbiyi OK, Sala A, Standing JF, Moghimi SM, Stoker AW, Hart SL. Tagalakis AD, et al. Among authors: maeshima r. Adv Funct Mater. 2021 Sep 9;31(37):2104843. doi: 10.1002/adfm.202104843. Epub 2021 Jun 30. Adv Funct Mater. 2021. PMID: 35712226 Free PMC article.
Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo.
Grant-Serroukh D, Hunter MR, Maeshima R, Tagalakis AD, Aldossary AM, Allahham N, Williams GR, Edbrooke M, Desai A, Hart SL. Grant-Serroukh D, et al. Among authors: maeshima r. J Control Release. 2022 Aug;348:786-797. doi: 10.1016/j.jconrel.2022.06.018. Epub 2022 Jun 26. J Control Release. 2022. PMID: 35718210 Free article.
Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing.
Walker AJ, Graham C, Greenwood M, Woodall M, Maeshima R, O'Hara-Wright M, Sanz DJ, Guerrini I, Aldossary AM, O'Callaghan C, Baines DL, Harrison PT, Hart SL. Walker AJ, et al. Among authors: maeshima r. Mol Ther Methods Clin Dev. 2023 Oct 18;31:101140. doi: 10.1016/j.omtm.2023.101140. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38027060 Free PMC article.
16 results